U.S. Markets open in 12 mins
  • S&P Futures

    4,623.50
    +57.25 (+1.25%)
     
  • Dow Futures

    34,785.00
    +328.00 (+0.95%)
     
  • Nasdaq Futures

    16,360.00
    +209.50 (+1.30%)
     
  • Russell 2000 Futures

    2,250.40
    +53.10 (+2.42%)
     
  • Crude Oil

    67.93
    +1.75 (+2.64%)
     
  • Gold

    1,790.40
    +13.90 (+0.78%)
     
  • Silver

    22.81
    -0.01 (-0.02%)
     
  • EUR/USD

    1.1339
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.4770
    +0.0340 (+2.36%)
     
  • Vix

    23.73
    +6.62 (+38.69%)
     
  • GBP/USD

    1.3341
    +0.0039 (+0.2948%)
     
  • USD/JPY

    113.0650
    -0.1150 (-0.1016%)
     
  • BTC-USD

    58,058.47
    -202.35 (-0.35%)
     
  • CMC Crypto 200

    1,481.79
    +13.86 (+0.94%)
     
  • FTSE 100

    7,159.27
    +99.82 (+1.41%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Annovis Bio, Inc. (NYSE:ANVS)

CONTACT JAKUBOWITZ ABOUT ANVS:
https://claimyourloss.com/securities/annovis-bio-inc-loss-submission-form/?id=20390&from=1

Class Period : May 21, 2021 - July 28, 2021

Lead Plaintiff Deadline : October 18, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eargo, Inc. (NASDAQ:EAR)

CONTACT JAKUBOWITZ ABOUT EAR:
https://claimyourloss.com/securities/eargo-inc-loss-submission-form/?id=20390&from=1

Class Period : October 16, 2020 - September 22, 2021

Lead Plaintiff Deadline : December 6, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Eargo had improperly sought reimbursements from certain third-party payors; (2) the foregoing was reasonably likely to lead to regulatory scrutiny; (3) as a result and because the reimbursements at issue involved the Company's largest third-party payor, Eargo's financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Hyzon Motors Inc. f/k/a Decarbonization Plus Acquisition Corporation (NASDAQ:HYZN)

CONTACT JAKUBOWITZ ABOUT HYZN:
https://claimyourloss.com/securities/hyzon-motors-inc-f-k-a-decarbonization-plus-acquisition-corporation-loss-submission-form/?id=20390&from=1

Class Period : February 9, 2021 - September 27, 2021

Lead Plaintiff Deadline : November 29, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Hyzon was misrepresenting the nature of its "customer" contracts and severely embellished its "deals" and "partnerships" with customers; (2) Hyzon could not deliver its announced vehicles in 2021, on its stated timeline; and (3) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/667923/LAWSUITS-FILED-AGAINST-ANVS-EAR-and-HYZN--Jakubowitz-Law-Pursues-Shareholders-Claims